127 related articles for article (PubMed ID: 2793377)
1. Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Jabboury K; Frye D; Holmes FA; Fraschini G; Hortobagyi G
Invest New Drugs; 1989 Jul; 7(2-3):225-9. PubMed ID: 2793377
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.
Warrell RP; Coonley CJ; Straus DJ; Young CW
Cancer; 1983 Jun; 51(11):1982-7. PubMed ID: 6839291
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.
Einhorn LH; Roth BJ; Ansari R; Dreicer R; Gonin R; Loehrer PJ
J Clin Oncol; 1994 Nov; 12(11):2271-6. PubMed ID: 7525884
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma.
Chitambar CR; Zahir SA; Ritch PS; Anderson T
Am J Clin Oncol; 1997 Apr; 20(2):173-8. PubMed ID: 9124195
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Adelson MD
Am J Clin Oncol; 1991 Aug; 14(4):349-51. PubMed ID: 1862766
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Warrell RP; Murphy WK; Schulman P; O'Dwyer PJ; Heller G
J Clin Oncol; 1991 Aug; 9(8):1467-75. PubMed ID: 1906532
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).
Chang AY; Tu ZN; Smith JL; Bonomi P; Smith TJ; Wiernik PH; Blum R
Invest New Drugs; 1995; 13(2):137-41. PubMed ID: 8617576
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer.
Senderowicz AM; Reid R; Headlee D; Abornathy T; Horti J; Lush RM; Reed E; Figg WD; Sausville EA
Urol Int; 1999; 63(2):120-5. PubMed ID: 10592501
[TBL] [Abstract][Full Text] [Related]
9. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD
Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.
Seidman AD; Scher HI; Heinemann MH; Bajorin DF; Sternberg CN; Dershaw DD; Silverberg M; Bosl GJ
Cancer; 1991 Dec; 68(12):2561-5. PubMed ID: 1933802
[TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
[TBL] [Abstract][Full Text] [Related]
13. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
14. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
[TBL] [Abstract][Full Text] [Related]
15. Gallium nitrate: the second metal with clinical activity.
Foster BJ; Clagett-Carr K; Hoth D; Leyland-Jones B
Cancer Treat Rep; 1986 Nov; 70(11):1311-9. PubMed ID: 3533251
[TBL] [Abstract][Full Text] [Related]
16. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
Baselga J; Kris MG; Scher HI; Phillips M; Heelan RT
Invest New Drugs; 1993 Feb; 11(1):85-6. PubMed ID: 8394297
[TBL] [Abstract][Full Text] [Related]
18. Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study.
Warrell RP; Lovett D; Dilmanian FA; Schneider R; Heelan RT
J Clin Oncol; 1993 Dec; 11(12):2443-50. PubMed ID: 8246033
[TBL] [Abstract][Full Text] [Related]
19. Gallium nitrate for advanced Paget disease of bone: effectiveness and dose-response analysis.
Warrell RP; Bosco B; Weinerman S; Levine B; Lane J; Bockman RS
Ann Intern Med; 1990 Dec; 113(11):847-51. PubMed ID: 2240900
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
